Skip to content

Étiquette : CE marking

First treatments with Valvosoft® now performed in routine clinical practice in Germany 🚀

By bertrand

First treatments with Valvosoft® now performed in routine clinical practice in Germany 🚀 June 11, 2026 Proud to see the first treatments with Cardiawave technology now performed in routine clinical practice in Germany 🇩🇪 ! Click here to read Prof. Jury Schewels’ Linkedin post:https://www.linkedin.com/posts/jury-schewel-pd-dr-med-817534153_aortenklappenstenose-ultraschallwellen-aortenklappe-activity-7468708705614663680-IZ3f?utm_source=share&utm_medium=member_desktop&rcm=ACoAABAOtEgBiS-TfTA24iH9k4ZIlQYsPVwEWhg Alongside Hôpital Européen Georges Pompidou in Paris and CHU de Rouen, these … Continued

Building momentum for Valvosoft® in Europe 🚀

By bertrand

Building momentum for Valvosoft® in Europe 🚀 May 28, 2026 Following its CE marking, we are seeing strong progress as Valvosoft® enters routine clinical use across Europe. In May, 8 additional patients were successfully treated for calcific aortic stenosis using Valvosoft®, our non-invasive ultrasound therapy developed by Cardiawave. 🏥 This continued activity marks an important step … Continued

🚀 2 patients successfully treated at HEGP !

By bertrand

🚀 2 patients successfully treated at HEGP ! April 23, 2026 🚀 2 patients were successfully treated last week at Hôpital Européen Georges-Pompidou (HEGP) with Valvosoft®, following its CE marking ✅ 🏥 This achievement represents an important step as Valvosoft® enters routine clinical use in Europe and highlights the close collaboration between innovative medtech teams and … Continued